Ramsay Générale de Santé SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000044471
EUR
9.26
-0.02 (-0.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With ROE of 2.87%, it has a Very Expensive valuation with a 0.93 Price to Book Value

  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -19.48%, its profits have fallen by -72.4%
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 996 Million ()

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.61

stock-summary
Return on Equity

2.87%

stock-summary
Price to Book

0.87

Revenue and Profits:
Net Sales:
448 Million
(Quarterly Results - Dec 2014)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.03%
0%
-7.03%
6 Months
-17.69%
0%
-17.69%
1 Year
-19.48%
0%
-19.48%
2 Years
-51.26%
0%
-51.26%
3 Years
-48.56%
0%
-48.56%
4 Years
-58.29%
0%
-58.29%
5 Years
-48.27%
0%
-48.27%

Ramsay Générale de Santé SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.51%
EBIT Growth (5y)
-16.81%
EBIT to Interest (avg)
5.18
Debt to EBITDA (avg)
2.87
Net Debt to Equity (avg)
1.79
Sales to Capital Employed (avg)
0.52
Tax Ratio
56.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.79%
ROE (avg)
14.46%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
0.93
EV to EBIT
29.85
EV to EBITDA
13.95
EV to Capital Employed
0.97
EV to Sales
1.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.25%
ROE (Latest)
2.87%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'14 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2014 is -4.70% vs -3.43% in Dec 2013",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2014 is -106.07% vs 531.58% in Dec 2013",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'14",
        "Dec'13",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "448.50",
          "val2": "470.60",
          "chgp": "-4.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.60",
          "val2": "56.30",
          "chgp": "-1.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "9.00",
          "chgp": "-44.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.10",
          "val2": "84.00",
          "chgp": "-106.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.10%",
          "val2": "55.50%",
          "chgp": "0.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is 4.70% vs 6.49% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is 4.63% vs -157.43% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,242.00",
          "val2": "5,006.50",
          "chgp": "4.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "621.40",
          "val2": "605.90",
          "chgp": "2.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "214.80",
          "val2": "205.40",
          "chgp": "4.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-39.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-35.00",
          "val2": "-36.70",
          "chgp": "4.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.70%",
          "val2": "35.80%",
          "chgp": "-0.01%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'14 - YoYstock-summary
Dec'14
Dec'13
Change(%)
Net Sales
448.50
470.60
-4.70%
Operating Profit (PBDIT) excl Other Income
55.60
56.30
-1.24%
Interest
5.00
9.00
-44.44%
Exceptional Items
-6.80
0.00
Consolidate Net Profit
-5.10
84.00
-106.07%
Operating Profit Margin (Excl OI)
61.10%
55.50%
0.56%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2014 is -4.70% vs -3.43% in Dec 2013

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2014 is -106.07% vs 531.58% in Dec 2013

Annual Results Snapshot (Consolidated) - Jun'25stock-summary
Jun'25
Jun'24
Change(%)
Net Sales
5,242.00
5,006.50
4.70%
Operating Profit (PBDIT) excl Other Income
621.40
605.90
2.56%
Interest
214.80
205.40
4.58%
Exceptional Items
0.00
-39.70
100.00%
Consolidate Net Profit
-35.00
-36.70
4.63%
Operating Profit Margin (Excl OI)
35.70%
35.80%
-0.01%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2025 is 4.70% vs 6.49% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2025 is 4.63% vs -157.43% in Jun 2024

stock-summaryCompany CV
About Ramsay Générale de Santé SA stock-summary
stock-summary
Ramsay Générale de Santé SA
Pharmaceuticals & Biotechnology
Ramsay Generale de Sante SA, formerly Generale de Sante SA (GDS), is a France-based company engaged in the provision of private hospital healthcare services. The Company offers a range of hospital services and, in partnership with independent medical specialists, delivers a spectrum of care services, including oncology and radiation therapy; care for alcohol abuse and obesity; rehabilitation, such as cardiac rehabilitation and orthopedic and neurological reeducation, and diagnostics, such as medical imaging and analysis. In addition, the Company develops a care package, offering care with personal support, before, during and after hospitalization. The Company operates approximately 75 centers and institutions in France. The Company operates through a number of subsidiaries, such as HPM Hopital Prive Metropole SAS. Ramsay Health Care (UK) Ltd is the major shareholder of the Company.
Company Coordinates stock-summary
Company Details
39 Rue Mstislav Rostropovitch , PARIS None : 75017
stock-summary
Tel: 33 1 87862300
stock-summary
Registrar Details